Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 12, 2009, Pages 1920-1924

  Thurman, Joshua M ^a   Marians, Russell ^b   Emlen, Woodruff ^b   Wood, Susan ^b   Smith, Christopher ^b   Akana, Hillary ^b   Holers, V Michael ^a   Lesser, Martin ^c   Kline, Myriam ^c   Hoffman, Cathy ^d   Christen, Erica ^d   Trachtman, Howard ^d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Taligen Therapeutics   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d Schneider Children's Hospital of North Shore LIJ Health System ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT; REGULATOR PROTEIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; DIALYSIS; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY INJURY; MALE; OUTCOMES RESEARCH; PREDICTION; PROTEIN BLOOD LEVEL;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COMPLEMENT FACTOR B; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT PATHWAY, ALTERNATIVE; DIARRHEA; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; MALE; RENAL DIALYSIS; RENAL INSUFFICIENCY, ACUTE; SEVERITY OF ILLNESS INDEX; THROMBOTIC MICROANGIOPATHIES;

EID: 73649122762     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02730409     Document Type: Article

References (11)

1. Tarr PI, Gordon CA, Chandler WL: Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073-1086, 2005
2. Hughes AK, Ergonul Z, Stricklett PK, Kohan DE: Molecular basis for high renal cell sensitivity to the cytotoxic effects of Shigatoxin-1: Upregulation of globotriaosylceramide expression. J Am Soc Nephrol 13: 2239-2245, 2002
3. Proulx F, Toledano B, Phan V, Clermont MJ, Mariscalco MM, Seidman EG: Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines with Escherichia coli O157:H7 associated with hemolytic uremic syndrome. Pediatr Res 52: 928-934, 2002
4. Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB: A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70: 423-431, 2006
5. Robson WL, Leung AK, Fick GHG, McKenna AI: Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 62: 296-298, 1992
6. Trachtman H, Christen E, Cnaan A, et al: Effect of a Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: A randomized controlled trial. JAMA 290: 1337-1344, 2003
7. Schulman SL, Kaplan BS: Management of patients with hemolytic uremic syndrome demonstrating severe azotemia but not oliguria. Pediatr Nephrol 10: 671-674, 1996
8. Ray P, Acheson D, Chitrakar R, Cnaan A, Gibbs K, Hirschman GH, Christen E, Trachtman H: Basic fibroblast growth factor among children with diarrhea-associated hemolytic uremic syndrome. J Am Soc Nephrol 13: 699-707, 2002
9. Trachtman H, Christen E, Cnaan A, Patrick J, Mai V, Mishra J, Jain A, Bullington N, Devarajan P: Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: A novel marker of renal injury. Pediatr Nephrol 21: 989-994, 2006
10. Westerholt S, Hartung T, Tollens M, Gustrau A, Oberhoffer M, Karch H, Klare B, Pfeffer K, Emmrich P, Oberhoffer R: Inflammatory and immunological parameters in children with haemolytic uremic syndrome(HUS) and gastroenteritis: Pathophysiological and diagnostic clues. Cytokine 12: 822-827, 2000
11. Holers VM: The spectrum of complement alternative pathway-mediated diseases. Immunol Rev 223: 300-316, 2008